山外山收盘上涨4.29%，滚动市盈率75.33倍，总市值55.49亿元

Group 1 - The core viewpoint of the news highlights the performance and valuation of Chongqing Mountain Outside Mountain Blood Purification Technology Co., Ltd., indicating a recent stock price increase and a notable PE ratio [1][2] - As of August 11, the company's stock closed at 17.27 yuan, up 4.29%, with a rolling PE ratio of 75.33, marking a new low in 268 days, and a total market capitalization of 5.549 billion yuan [1] - The average PE ratio in the medical device industry is 56.56, with a median of 39.76, positioning the company at 94th in the industry ranking [1][3] Group 2 - The company specializes in the research, production, and sales of blood purification equipment and consumables, as well as providing chain blood dialysis medical services [2] - Key products include blood perfusion machines, continuous blood purification devices, and various types of dialysis machines and consumables [2] - The company has received multiple national and provincial awards for its innovations, including the National Science and Technology Progress Award [2] Group 3 - In the latest quarterly report for Q1 2025, the company achieved an operating income of 189 million yuan, representing a year-on-year increase of 16.77%, and a net profit of 37.064 million yuan, up 8.10% year-on-year, with a gross profit margin of 46.72% [2]